BiotechTube
Home/Cue Biopharma/Daniel Baker
DB

Daniel Baker

Interim Chief Development Officer

Cue Biopharma

Therapeutic Areas

Autoimmune DiseasesOncology

Cue Biopharma Pipeline

DrugIndicationPhase
CUE-401Autoimmune and Inflammatory DiseasesPreclinical

Leadership Team at Cue Biopharma

LW
Lucinda Warren
Interim President and Chief Executive Officer
CS
Colin Sandercock
Senior Vice President and General Counsel
View full Cue Biopharma profile